What does PHARMACIE CAKIR DE BRESSOUX do?

PHARMACIE CAKIR DE BRESSOUX is a pharmacy in Liège. Private Limited, started on 26 December 2019, 1 establishment.

What is the address of PHARMACIE CAKIR DE BRESSOUX?

The registered office of PHARMACIE CAKIR DE BRESSOUX is located at Rue Foidart 50, 4020 Liège.

Is PHARMACIE CAKIR DE BRESSOUX still active?

Yes. According to the CBE (3 October 2026) PHARMACIE CAKIR DE BRESSOUX is active, legal situation “Normale toestand”, started on 26 December 2019.

Is PHARMACIE CAKIR DE BRESSOUX registered on Peppol?

Yes, PHARMACIE CAKIR DE BRESSOUX is registered on the Peppol network with ID 0208:0740500968.

What is the enterprise number of PHARMACIE CAKIR DE BRESSOUX?

The enterprise number of PHARMACIE CAKIR DE BRESSOUX is BE0740500968.

When was PHARMACIE CAKIR DE BRESSOUX founded?

PHARMACIE CAKIR DE BRESSOUX was founded on 26 December 2019.

Who are the directors of PHARMACIE CAKIR DE BRESSOUX?

According to the 2025 annual accounts, the directors of PHARMACIE CAKIR DE BRESSOUX are: CAKIR MANAGEMENT.

Is PHARMACIE CAKIR DE BRESSOUX a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 December 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMACIE CAKIR DE BRESSOUX make in 2025?

PHARMACIE CAKIR DE BRESSOUX recorded a loss after taxes of € 92,322 in financial year 2025.

What is the revenue of PHARMACIE CAKIR DE BRESSOUX?

As a small company, PHARMACIE CAKIR DE BRESSOUX is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 136,708.

How much does an employee at PHARMACIE CAKIR DE BRESSOUX earn?

The average wage cost per full-time employee at PHARMACIE CAKIR DE BRESSOUX was € 42,400 in 2025: staff costs of € 84,745 for 2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE CAKIR DE BRESSOUX have?

According to the 2025 annual accounts, PHARMACIE CAKIR DE BRESSOUX has 2 full-time equivalents (FTE).

PHARMACIE CAKIR DE BRESSOUX (Private Limited) - Liège

Dossier PHARMACIE CAKIR DE BRESSOUX, printed on 3 October 2026 from databakkes.be/en/0740500968/pharmacie-cakir-de-bressoux. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.

Financials

Financial year 2025

PHARMACIE CAKIR DE BRESSOUX from Liège, company number BE0740500968, closed financial year 2025 with a result of € -92,322 after tax. For that financial year PHARMACIE CAKIR DE BRESSOUX recorded a gross margin of € 136,708 and equity of € 23,820. Compared with financial year 2024, the result moved from € -102,970 to € -92,322. The company made a loss. The buffer shrank hard: equity is 79 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Shrank hard

€ 23,820

▼ 79% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -92,322

▲ 10 % less loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 10,651

▼ 6% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 13,820.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 84,745

▼ 9% vs 2024

€ 42,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 84,908

▼ 27% vs 2024

Of which on lease € 52,579.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 467,687

▼ 16% vs 2024

€ 89,824 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 230,694

▼ 25% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 13,645

▼ 54% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 217,000 Gross margin 2022: € 217,000 First fiscal year in the series	€ 214,109 Gross margin 2023: € 214,109 ▼ 1% vs 2022 (€ 217,000) Unfavourable step	€ 92,066 Gross margin 2024: € 92,066 ▼ 57% vs 2023 (€ 214,109) Unfavourable step	€ 136,708 Gross margin 2025: € 136,708 ▲ 48% vs 2024 (€ 92,066) Favourable step	▲ 48%
Profit after taxes	€ 82,497 Profit after taxes 2022: € 82,497 First fiscal year in the series	€ 52,331 Profit after taxes 2023: € 52,331 ▼ 37% vs 2022 (€ 82,497) Unfavourable step	€ -102,970 Profit after taxes 2024: € -102,970 ▼ € 155,300 vs 2023 (€ 52,331) Unfavourable step	€ -92,322 Profit after taxes 2025: € -92,322 ▲ € 10,648 vs 2024 (€ -102,970) Favourable step	▲ € 10,648
Equity	€ 166,781 Equity 2022: € 166,781 First fiscal year in the series	€ 219,111 Equity 2023: € 219,111 ▲ 31% vs 2022 (€ 166,781) Favourable step	€ 116,142 Equity 2024: € 116,142 ▼ 47% vs 2023 (€ 219,111) Unfavourable step	€ 23,820 Equity 2025: € 23,820 ▼ 79% vs 2024 (€ 116,142) Unfavourable step	▼ 79%
Total debts	€ 311,194 Total debts 2022: € 311,194 First fiscal year in the series	€ 537,762 Total debts 2023: € 537,762 ▲ 73% vs 2022 (€ 311,194) Unfavourable step	€ 891,680 Total debts 2024: € 891,680 ▲ 66% vs 2023 (€ 537,762) Unfavourable step	€ 733,542 Total debts 2025: € 733,542 ▼ 18% vs 2024 (€ 891,680) Favourable step	▼ 18%
Cash	€ 102,742 Cash 2022: € 102,742 First fiscal year in the series	€ 46,387 Cash 2023: € 46,387 ▼ 55% vs 2022 (€ 102,742) Unfavourable step	€ 11,285 Cash 2024: € 11,285 ▼ 76% vs 2023 (€ 46,387) Unfavourable step	€ 10,651 Cash 2025: € 10,651 ▼ 6% vs 2024 (€ 11,285) Unfavourable step	▼ 6%
Retained profit	€ 156,781 Retained profit 2022: € 156,781 First fiscal year in the series	€ 209,111 Retained profit 2023: € 209,111 ▲ 33% vs 2022 (€ 156,781) Favourable step	€ 106,142 Retained profit 2024: € 106,142 ▼ 49% vs 2023 (€ 209,111) Unfavourable step	€ 13,820 Retained profit 2025: € 13,820 ▼ 87% vs 2024 (€ 106,142) Unfavourable step	▼ 87%
Dividend	€ 1,600 Dividend 2022: € 1,600 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 1,600) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 149,404 Bank debt 2022: € 149,404 First fiscal year in the series	€ 450,386 Bank debt 2023: € 450,386 ▲ 201% vs 2022 (€ 149,404) Unfavourable step	€ 556,317 Bank debt 2024: € 556,317 ▲ 24% vs 2023 (€ 450,386) Unfavourable step	€ 467,687 Bank debt 2025: € 467,687 ▼ 16% vs 2024 (€ 556,317) Favourable step	▼ 16%
Balance sheet total	€ 477,975 Balance sheet total 2022: € 477,975 First fiscal year in the series	€ 756,873 Balance sheet total 2023: € 756,873 ▲ 58% vs 2022 (€ 477,975) Unchanged	€ 1,007,822 Balance sheet total 2024: € 1,007,822 ▲ 33% vs 2023 (€ 756,873) Unchanged	€ 757,361 Balance sheet total 2025: € 757,361 ▼ 25% vs 2024 (€ 1,007,822) Unchanged	▼ 25%
Employees (FTE)	2.5 Employees (FTE) 2022: 2.5 First fiscal year in the series	-	-	2 Employees (FTE) 2025: 2 First fiscal year in the series

Key figures of PHARMACIE CAKIR DE BRESSOUX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE CAKIR DE BRESSOUX?

What happened at PHARMACIE CAKIR DE BRESSOUX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: loss of € 92,322. filed late Source: NBB ↗
2024 CAKIR MANAGEMENT became a director. NBB
Jan 1, 2020 New establishment in Liège. KBO
Dec 26, 2019 Start of the company according to the CBE. KBO

In short

From € 82,497 profit in 2022 to € 92,322 loss in 2025.

Paid € 34,491 in corporate taxes since 2022.

Best year ever: 2022, with € 82,497 profit.

On average € 68,400 of value added per employee in 2025.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMACIE CAKIR DE BRESSOUX? We notify you, reason included.

Follow PHARMACIE CAKIR DE BRESSOUX

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit